Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 1/2 3Phase 3 2Phase NA 1Phase 2/3 1Phase 1 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 32Colonic Neoplasms 20Rectal Neoplasms 11Carcinoma, Hepatocellular 7Neoplasm Metastasis 5Stomach Neoplasms 2Neoplastic Cells, Circulating 2Neoplasms 2Liver Neoplasms 2Recurrence 1Peritoneal Neoplasms 1Pathologic Complete Response 1Pancreatic Neoplasms 1Oligometastatic Gastric Adenocarcinoma 1Neuroendocrine Tumors 1Neoplasms, Second Primary 1Neoplasm, Residual 1Neoplasm Recurrence, Local 1Margins of Excision 1Locally Advanced Rectal Cancer 1Gastro-enteropancreatic neuroendocrine tumor 1Gallbladder Neoplasms 1Cholangiocarcinoma 1Biliary Tract Neoplasms 1

Interventions

Oxaliplatin 56Capecitabine 49Fluorouracil 37Cisplatin 37S 1 (combination) 23Paclitaxel 18Docetaxel 18Leucovorin 16pembrolizumab 13Irinotecan 12apatinib 11titanium silicide 9XELOX 9Trastuzumab 9Nivolumab 9Hyperthermic Intraperitoneal Chemotherapy 8Epirubicin 8Drug Therapy 8Tegafur 7Radiotherapy 6Neoadjuvant Therapy 6gimeracil 5Surgical Procedures, Operative 5Gastrectomy 5Chemotherapy, Adjuvant 5tislelizumab 4S-1 plus cisplatin 4Ramucirumab 4zolbetuximab 3sintilimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Stomach Neoplasms × Folfox protocol × Clear all
NCT06346197 2026-04-21

CIME

Centre Leon Berard

Phase 3 Recruiting
132 enrolled
Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

NCT01748851 2014-11-04

XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC)

Dong-A University Hospital

Phase 3 Terminated
42 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡